Citigroup’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-75
| Closed | -$33 | – | 4946 |
|
|
2024
Q3 | $33 | Hold |
75
| – | – | ﹤0.01% | 4750 |
|
|
2024
Q2 | $199 | Hold |
75
| – | – | ﹤0.01% | 4652 |
|
|
2024
Q1 | $206 | Hold |
75
| – | – | ﹤0.01% | 4683 |
|
|
2023
Q4 | $182 | Hold |
75
| – | – | ﹤0.01% | 4725 |
|
|
2023
Q3 | $152 | Hold |
75
| – | – | ﹤0.01% | 4583 |
|
|
2023
Q2 | $221 | Buy |
75
+19
| +34% | +$56 | ﹤0.01% | 4662 |
|
|
2023
Q1 | $140 | Sell |
56
-1,461
| -96% | -$3.65K | ﹤0.01% | 4535 |
|
|
2022
Q4 | $4.81K | Buy |
1,517
+549
| +57% | +$1.74K | ﹤0.01% | 4304 |
|
|
2022
Q3 | $3K | Sell |
968
-9,327
| -91% | -$28.9K | ﹤0.01% | 4558 |
|
|
2022
Q2 | $31K | Buy |
10,295
+4,908
| +91% | +$14.8K | ﹤0.01% | 4078 |
|
|
2022
Q1 | $73K | Sell |
5,387
-5,025
| -48% | -$68.1K | ﹤0.01% | 3872 |
|
|
2021
Q4 | $136K | Sell |
10,412
-231,652
| -96% | -$3.03M | ﹤0.01% | 3807 |
|
|
2021
Q3 | $2.27M | Buy |
242,064
+176,301
| +268% | +$1.65M | ﹤0.01% | 1819 |
|
|
2021
Q2 | $673K | Buy |
65,763
+64,738
| +6,316% | +$663K | ﹤0.01% | 2870 |
|
|
2021
Q1 | $19K | Sell |
1,025
-1,376
| -57% | -$25.5K | ﹤0.01% | 4612 |
|
|
2020
Q4 | $82K | Buy |
+2,401
| New | +$82K | ﹤0.01% | 3807 |
|